MA-BENU-NETWORKS
13.8.2019 13:37:10 CEST | Business Wire | Press release
Benu Networks , the leading software and solutions provider simplifying the industry’s most complex edge networks, announced the launch of its new virtual broadband network gateway (vBNG ). This new network function builds upon Benu Networks’ Software-Defined Edge (SD-Edge) Platform, which features a set of rich, virtualized functionalities that enable service providers to instantly cloudify their network, rapidly create and deliver new services, and easily scale network performance.
Modern consumer expectation and demand, particularly from the lens of a managed service provider, is constantly shifting. Buying behavior and criteria have drastically changed - gone are the days when triple play deals created great value to consumers and helped drive ARPU growth for service providers. Nowadays, residential subscribers are moving to single play broadband access, which adds pressure for managed service providers to create customized, cutting-edge offerings that continue to impress consumers. However, this level of agility has proved difficult to achieve for most MSPs, who still depend on hardware to manage subscriber sessions, authentication, and more. Plus, the need to reduce operational and capital expenses in the midst of margin erosion adds an additional layer of complexity for MSPs to manage.
“Our network has relied on Benu Networks’ software for 4 years, on dedicated appliances. We’re thrilled to see the addition of a vBNG to their platform,” said Khetan Gajjar, CTO of VAST Networks. “One of the key challenges we face, particularly as Africa’s leading Wi-Fi provider of services, is our ability to be agile and dynamic with the services we offer and scaling these efficiently while retaining our standard of performance. We currently do this with the SD-Edge Platform to millions of users. Now, with the Benu vBNG, we won’t have to think too hard about the scaling required to tailor services to each customer and building out new offerings and scaling to tens and hundreds of millions of users. A vBNG also allows us to deliver network scale much closer to the edge and allows us to expand into markets much more cost-effectively.”
The vBNG, running on the Benu SD-Edge Platform, helps service providers achieve this vision by streamlining packet processing as well as separating the control plane and data plane for dynamic scaling, added agility, optimal network performance, and cost reduction. The flexible, open architecture supports 3rd party service stitching on top of the breadth of functionality native to the vBNG. Service providers can now consolidate functions such as TDF/DPI, CGNAT, SG, and BNG, into a single virtualized platform for ultra-low latency and high performance. With the Benu Networks vBNG, service providers can go beyond just providing a ‘dumb pipe’ broadband connection and instead rapidly provision value-added services that reduce churn and increase ARPU.
“Releasing our vBNG as a part of the Benu SD-Edge Platform furthers our mission to simplify edge applications, “ said Mads Lillelund, CEO of Benu Networks. “We’re looking to drastically simplify network transformation and make it easy for service providers to be more agile and innovative without locking them into one vendor. With our vBNG, we’ve taken a massive step toward achieving this goal.”
The vBNG virtualizes integral network functionality, empowering service providers to seamlessly transition to a cloud-based 5G ready network. Benu Networks’ technology simplifies the complexity of network optimization, helping service providers rapidly scale their offerings, manage their network, and ensure the service experience. By disaggregating legacy network structures and eliminating hardware dependencies, service providers are free to move towards a modern network, reduce costs, and improve customer experience.
To schedule a demo, visit https://benunetworks.com/contact-us/ .
About Benu Networks:
Benu Networks is a leading software and solutions provider, simplifying the industry’s most complex edge networks. With a comprehensive set of products and innovative solutions coupled with over a decade in the industry, Benu Networks delivers solutions to instantly transform legacy access networks, elastically manage services, and carve the path to 5G. For more information, please visit the Benu Networks’ website: www.benunetworks.com . Follow us on Twitter @benunets.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190813005390/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 17:08:00 CEST | Press release
HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 202612.6.2026 12:00:00 CEST | Press release
Tacabrutideg (BGB-16673, BTK degrader) showed durable responses in heavily pretreated R/R CLL and BTK inhibitor–naïve patients, signaling potential for earlier lines of treatmentBRUKINSA plus sonrotoclax (ZS) delivered deep, durable responses and high uMRD rates across TN CLL and R/R MCL and CLL, reinforcing its potential as an all-oral, fixed-duration treatment BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from its foundational hematology franchise at the 2026 European Hematology Association (EHA) Congress in Stockholm. Updated results from tacabrutideg (BGB-16673), a potential best-in-class Bruton’s tyrosine kinase (BTK) degrader, demonstrated durable responses in pretreated relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), with early activity also seen in BTK inhibitor–naïve patients. These data are complemented by results from the all-oral combination of BRUKINSA® (zanubru
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
